219 related articles for article (PubMed ID: 14872436)
1. Strategies for minimizing blood loss in orthopedic surgery.
Tobias JD
Semin Hematol; 2004 Jan; 41(1 Suppl 1):145-56. PubMed ID: 14872436
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic drugs.
Mannucci PM
N Engl J Med; 1998 Jul; 339(4):245-53. PubMed ID: 9673304
[No Abstract] [Full Text] [Related]
3. Intraoperative blood management in joint replacement surgery.
Tenholder M; Cushner FD
Orthopedics; 2004 Jun; 27(6 Suppl):s663-8. PubMed ID: 15239554
[TBL] [Abstract][Full Text] [Related]
4. Blood conservation in cardiac surgery.
Anderson L
J Perioper Pract; 2010 Dec; 20(12):436-9. PubMed ID: 21265402
[TBL] [Abstract][Full Text] [Related]
5. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators.
Laupacis A; Fergusson D
Anesth Analg; 1997 Dec; 85(6):1258-67. PubMed ID: 9390590
[TBL] [Abstract][Full Text] [Related]
6. [The "Seville" Consensus Document on Alternatives to Allogenic Blood Transfusion. Sociedades españolas de Anestesiología (SEDAR), Medicina Intensiva (SEMICYUC), Hematología y Hemoterapia (AEHH), Transfusión sanguínea (SETS) Trombosis y Hemostasia (SETH)].
Alberca I; Asuero MS; Bóveda JL; Carpio N; Contreras E; Fernández-Mondéjar E; Forteza A; García-Erce JA; García de Lorenzo A; Gomar C; Gómez A; Llau JV; López-Fernández MF; Moral V; Muñoz M; Páramo JA; Torrabadella P; Quintana M; Sánchez C
Med Clin (Barc); 2006 Jul; 127 Suppl 1():3-20. PubMed ID: 17020674
[TBL] [Abstract][Full Text] [Related]
7. Technologies to minimize blood transfusion in cardiac and orthopedic surgery. Results of a practice variation survey in nine countries. International Study of Peri-operative Transfusion (ISPOT) Investigators.
Fergusson D; Blair A; Henry D; Hisashige A; Huet C; Koopman-van Gemert A; Katz E; McClelland B; Sigmund H; Laupacis A
Int J Technol Assess Health Care; 1999; 15(4):717-28. PubMed ID: 10645113
[TBL] [Abstract][Full Text] [Related]
8. Strategies for minimizing the use of allogeneic blood during orthopedic surgery.
Rosenblatt MA
Mt Sinai J Med; 2002; 69(1-2):83-7. PubMed ID: 11832977
[TBL] [Abstract][Full Text] [Related]
9. Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery.
Scott JP; Costigan DJ; Hoffman GM; Simpson PM; Dasgupta M; Punzalan R; Berens RJ; Tweddell JS; Stuth EA
J Clin Anesth; 2014 May; 26(3):204-11. PubMed ID: 24809789
[TBL] [Abstract][Full Text] [Related]
10. [Drugs to reduce transfusion needs during surgery].
Pleym H
Tidsskr Nor Laegeforen; 2008 Apr; 128(7):829-30. PubMed ID: 18389031
[TBL] [Abstract][Full Text] [Related]
11. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
Zufferey P; Merquiol F; Laporte S; Decousus H; Mismetti P; Auboyer C; Samama CM; Molliex S
Anesthesiology; 2006 Nov; 105(5):1034-46. PubMed ID: 17065899
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
Levi M; Cromheecke ME; de Jonge E; Prins MH; de Mol BJ; Briët E; Büller HR
Lancet; 1999 Dec; 354(9194):1940-7. PubMed ID: 10622296
[TBL] [Abstract][Full Text] [Related]
13. Methods of reducing allogeneic blood demand in orthopedic surgery.
Dragan S; Kulej M; Krawczyk A; Wall A; Płocieniak K; Urbański W
Ortop Traumatol Rehabil; 2012; 14(3):199-214. PubMed ID: 22764333
[TBL] [Abstract][Full Text] [Related]
14. Antifibrinolytics in major orthopaedic surgery.
Eubanks JD
J Am Acad Orthop Surg; 2010 Mar; 18(3):132-8. PubMed ID: 20190103
[TBL] [Abstract][Full Text] [Related]
15. Current status of non-transfusional haemostatic agents.
Cattaneo M; Mannucci PM
Haematologica; 1999 Jun; 84 Suppl EHA-4():120-3. PubMed ID: 10907488
[No Abstract] [Full Text] [Related]
16. [Blood conservation approaches in orthopedic surgery].
Rosencher N; Bellamy L; Chabbouh T; Arnaout L; Ozier Y
Transfus Clin Biol; 2008 Nov; 15(5):294-302. PubMed ID: 18930421
[TBL] [Abstract][Full Text] [Related]
17. Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy.
Gunaydin B; Ozkose Z; Pezek S
J Anesth; 2007; 21(1):106-7. PubMed ID: 17285428
[No Abstract] [Full Text] [Related]
18. Pharmacological approaches to reducing blood loss and transfusions in the surgical patient.
Ozier Y; Schlumberger S
Can J Anaesth; 2006 Jun; 53(6 Suppl):S21-9. PubMed ID: 16766788
[TBL] [Abstract][Full Text] [Related]
19. Conservation of blood during cardiovascular surgery.
Cooley DA
Am J Surg; 1995 Dec; 170(6A Suppl):53S-59S. PubMed ID: 8546249
[TBL] [Abstract][Full Text] [Related]
20. The use of technologies to decrease peri-operative allogenic blood transfusion: results of practice variation in Israel.
Katz E; Gaitini L; Samri M; Egoz N; Fergusson D; Laupacis A
Isr Med Assoc J; 2001 Nov; 3(11):809-12. PubMed ID: 11729574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
